![]() |
![]() |
(7S,11S,12R,13S,14R,15R,16R,17S,18S,21Z)-2,15,17,23,27,29-Hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,23,2 2,7-(Epoxy[1,11,13]pentadecatrien[1]yl[15]ylidenenitrilo)naphtho[2,1-b]furan-1(2H)-one, 21-(acetyloxy)-5,6,9,11,17,19-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, sodium salt, (2S,10E,12Z,1 4Z,16S,17S,18R,19R,20R,21S,22R,23S,24Z)- (1:1) 2,7-(Epoxy[1,11,13]pentadecatrien[1]yl[15]ylidenenitrilo)naphtho[2,1-b]furan-1(2H)-one, 21-(acetyloxy)-5,6,9,11,17,19-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, sodium salt, (2S,12Z,16S,1 7S,18R,19R,20R,21S,22R,23S)- (1:1) 2,7-(Epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, sodium salt, (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)- (1:1) 2,7-(Epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-21-carboxylic acid, 1,2-dihydro-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-, methyl ester, sodium salt, ( 2S,12E,14E,16R,17R,18R,19R,20R,21R,22R,23R,24E)- (1:1) 238-965-7 5(29),26-nonaen-13-yl acetate - sodium (1:1) 5,6,9,17,19,21-Hexahydroxy-23-Methoxy-2,4,12,16,18,20,22-heptaMethyl 8]triaconta-1(29),2,4,9,19,21,25,27-octaen-27-olate EINECS 238-965-7 MFCD00056847 monosodium rifamycin SV onta-1(28),2,4,9,19,21,23,25(29),26-nonaen-27-olate RIFAMPICIN SV SODIUM Rifamycin sodium salt Rifamycin SV hexahydrate sodium salt Rifamycin SV Monosodium RifaMycin SV MonosodiuM salt Rifamycin SV s RIFAMYCIN SV SODIUM SALT RIFAMYCIN SV SODIUM SALT HEXAHYDRATE Rifamycin SV sodium, >=900 IU/mg RIFAMYCIN SV-SODIUM RifaMycin, sodiuM salt (1:1) RIFAMYCIN,MONOSODIUMSALT Sodium (7S,9E,11R,12R,13R,14R,15R,16R,17R,18R,19E,21E)-2,15,17,29-tetrahydroxy-11-methoxy-13-(methoxycarbonyl)-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,2 Sodium (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-13-acetoxy-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1.0]triacon ta-1(28),2,4,9,19,21,25(29),26-octaen-27-olate Sodium (7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z,23E)-13-acetoxy-2,15,17,23,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6-oxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triac
Eye irritation, Category 2
Pictogram(s) | ![]() |
---|---|
Signal word | Warning |
Hazard statement(s) | H319 Causes serious eye irritation |
Precautionary statement(s) | |
Prevention | P264 Wash ... thoroughly after handling. P280 Wear protective gloves/protective clothing/eye protection/face protection. |
Response | P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 If eye irritation persists: Get medical advice/attention. |
Storage | none |
Disposal | none |
none